Further, the measurements show an increase in E2, INS, FPG, IPSS, and HOMA‐IR as well as a reduction in TT, SHBG, Qmax, and PSA in MetS patients compared with Non‐MetS patients. This evidence concerns the gene INS and metabolic syndrome.